The Private Equity and Life Sciences teams advised Ampersand Capital Partners in the acquisition of Nektar’s (NASDAQ: NKTR) PEGylation reagent supply business and related commercial-scale manufacturing facility. The new Ampersand portfolio company will be branded Gannet BioChem and will continue to operate out of its facility in Huntsville, Alabama.
Ampersand Capital Partners is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors.
Nektar is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar is headquartered in San Francisco, California.
Gannet BioChem is a leading specialty CDMO specializing in the development, scaling, and manufacturing of polyethylene glycol (PEG) reagents—essential components in advanced biopharmaceutical and therapeutic products. Operating from a state-of-the-art 124,000 sq. ft. FDA-inspected facility in Huntsville, Alabama, Gannet BioChem delivers end-to-end GMP production, supporting clinical and commercial therapeutics. With a highly experienced team, flexible production capabilities, and a commitment to quality, Gannet BioChem provides reliable, innovative solutions to meet the evolving needs of the global biopharmaceutical industry.
The Goodwin team was led by included Jim Barrett, Eric Carlson, Jon Berke, Ryan Peloquin and Brittany Leon; Shannyn Henke, Kelly Song and Evan De Ycaza; Timothy Holahan, Brendan Lally-McGurl and Janelle Dempsey; Malhar Naik, Morgan Frisoli and Rahat Tariq; Jacqueline Klosek and Isabelle Staff; Richard Matheny and Gozde Guckaya; Andy Sucoff; Nate Brodeur; Daniel Karelitz and Nicole Brock; Ai Tajima and Shelby Hecht with invaluable assistance from Michele Urann.
For more information, please read the press release.